- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 11/10 - Expectorants
Patent holdings for IPC class A61P 11/10
Total number of patents in this class: 120
10-year publication summary
4
|
9
|
6
|
5
|
8
|
6
|
25
|
10
|
7
|
1
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Vertex Pharmaceuticals Incorporated | 1581 |
8 |
Institute of Materia Medica, Chinese Academy of Medical Sciences | 165 |
7 |
Pulmatrix, Inc. | 25 |
4 |
Taisho Pharmaceutical Co., Ltd. | 844 |
4 |
Yamaha Corporation | 4054 |
3 |
Chengdu Shibeikang Biomedical Technology Co., Ltd. | 12 |
3 |
The Procter & Gamble Company | 22178 |
2 |
Novartis AG | 11238 |
2 |
Chiesi Farmaceutici S.p.A. | 940 |
2 |
Daiichi Sankyo Company, Limited | 1829 |
2 |
Maria Clementine Martin Klosterfrau Vertriebsgesellschaft mbH | 123 |
2 |
Pulmatrix Operating Company, Inc. | 44 |
2 |
Sun Yat-sen University | 584 |
2 |
URGO Recherche Innovation et Developpement | 287 |
2 |
Guangzhou Institute of Respiratory Disease | 10 |
2 |
Neilos S.r.l. | 82 |
2 |
Czap Research and Development, LLC | 10 |
2 |
Hunan Aidalun Technology Co., Ltd. | 4 |
2 |
Pathios Therapeutics Limited | 15 |
2 |
F. Hoffmann-La Roche AG | 7958 |
1 |
Other owners | 64 |